RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment: a Prospective, Multicentric, Cohort Study (RAISE)
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of rimegepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of migraine without aura, migraine with aura, or chronic migraine according to the 3rd edition of the International Classification of Headache Disorder (ICHD-III);
• At least 4 monthly migraine days;
• Good compliance to study procedures;
• Availability of headache diary at least of the preceding months before enrollment.
Locations
Other Locations
Italy
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
RECRUITING
Florence
IRCCS National Neurological Institute C. Mondino Foundation
RECRUITING
Pavia
Contact Information
Primary
Luigi F Iannone, MD
lluigifrancesco.iannone@unifi.it
+393896969606
Backup
Roberto De Icco, MD
roberto.deicco@mondino.it
+390382380479
Time Frame
Start Date: 2024-03-26
Estimated Completion Date: 2026-01
Participants
Target number of participants: 100
Treatments
Episodic migraine
Patients affected by an episodic pattern migraine(\< 15 monthly headache days) with or without aura according to ICHD-III criteria.
Chronic migraine
Patients affected by chronic migraine (\> 15 monthly headache days with at least 8 days with migraine features) according to ICHD-III criteria.
Related Therapeutic Areas
Sponsors
Collaborators: Azienda Ospedaliero Universitaria Policlinico Modena, Azienda Ospedaliera S. Maria della Misericordia, Azienda Policlinico Umberto I, Azienda Ospedaliero-Universitaria di Parma, Auxologico San Luca, Asst Degli Spedali Civili Di Brescia, Università degli Studi dell'Aquila, University of Campania Luigi Vanvitelli, Ospedale Santo Stefano, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Cliniche Humanitas Gavazzeni, IRCCS National Neurological Institute C. Mondino Foundation, A.O.U. Città della Salute e della Scienza, University of Roma La Sapienza, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Società Italiana per lo Studio delle Cefalee, Ospedale di Piove di Sacco
Leads: University of Florence